Search Within

Robert R Jenq

Formats
  1. Meeting Abstract (58)
  2. Journal Article (48)
  3. Book Section (1)
Groups
  1. Department of Medicine (107)
  2. Hematologic Malignancies, Division of (107)
  3. Center for Hematologic Malignancies (102)
  4. GSK Faculty (100)
  5. Sloan Kettering Institute Faculty (97)
  6. Immunology Program Faculty (96)

More Groups

People
  1. Marcel Van Den Brink (94)
  2. Odette Smith (46)
  3. Alan Hanash (44)
  4. Amanda Holland (38)
  5. Arnab Ghosh (27)
  6. Miguel-Angel Perales (26)

More People

Years
  1. 2018 (5)
  2. 2017 (8)
  3. 2016 (12)
  4. 2015 (15)
  5. 2014 (7)
  6. 2013 (7)

More Years

Publications
  1. Blood (31)
  2. Biology of Blood and Marrow Transplantation (30)
  3. Bone Marrow Transplantation (5)
  4. PLoS ONE (5)
  5. Journal of Clinical Investigation (3)
  6. Journal of Clinical Oncology (3)

More Publications

Publishers
  1. American Society of Hematology (32)
  2. Elsevier Inc. (31)
  3. Nature Publishing Group (12)
  4. Public Library of Science (5)
  5. American Association for the Advancement of Science (3)
  6. American Society for Clinical Investigation (3)

More Publishers

Results (107)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Off-the-shelf tumor immunotherapy with genetically enhanced allogeneic T-cell precursors
    Meeting Abstract

    Zakrzewski, J. L.; Suh, D.; Markley, J. C.; Smith, O. M.; King, C.; Goldberg, G.; Jenq, R.; Holland, A. M.; Grubin, J.; Cabrera-Perez, J.; more...
    Biology of Blood and Marrow Transplantation (2008)

    Fulltext@MSK | Save
  • Depletion of vascular endothelial progenitor cells inhibits inflammation
    Meeting Abstract

    Penack, O.; Henke, E.; Suh, D.; King, C.; Smith, M. O.; Na, I. K.; Holland, A.; Ghosh, A.; Lu, S. X.; Jenq, R.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • The T cell cytolytic molecules Fas ligand and TRAIL, the trafficking molecules CCR9, β7 integrin and PSGL-1, and the immune modulating molecules OX40, CEACAM1, and CTLA4 are required for thymic graft-versus-host disease
    Meeting Abstract

    Na, I. K.; Lu, S. X.; Goldberg, G. L.; Hirschhorn Cymerman, D. D.; King, C. G.; Smith, O. M.; Suh, D.; Rao, U.; Yim, N.; Holland, A. M.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors
    Journal Article

    Zakrzewski, J. L.; Suh, D.; Markley, J. C.; Smith, O. M.; King, C.; Goldberg, G. L.; Jenq, R.; Holland, A. M.; Grubin, J.; Cabrera-Perez, J.; more...
    Nature Biotechnology (2008)

    Fulltext@MSK | Save
  • Agonist anti-GITR antibody induces CD8 T cell-mediated tumor rejection
    Meeting Abstract

    Cohen, A. D.; Diab, A.; Perales, M. A.; Duan, F.; Jenq, R.; Rizzuto, G.; Hirschorn-Cymmerman, D.; Merghoub, T.; Wolchok, J. D.; Houghton, A. N.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Immunomodulatory molecules of the immune system
    Book Section

    Saenger, Y. M.; Jenq, R. R.; Perales, M. A.
    In Kaufman, H. L.; Wolchok, J. D. (Eds.) General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology (2007)

    Fulltext@MSK | Save
  • Targeted 'Off-the-Shelf' tumor immunotherapy using allogeneic T-Cell precursors
    Meeting Abstract

    Zakrzewski, J. L.; Suh, D.; Smith, O. M.; King, C.; Goldberg, G. L.; Jenq, R.; Holland, A. M.; Grubin, J.; Lu, S. X.; Cabrera-Perez, J.; more...
    Blood (2007)

    Fulltext@MSK | Save